Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Gastrointestinal (GI) cancers are associated with high morbidity and mortality. Surgical resection, the primary treatment, often induces immunosuppression and increases the risk of postoperative complications. Perioperative immunonutrition (IMN), comprising formulations enriched with omega-3 fatty acids, arginine, nucleotides, and antioxidants, has emerged as a potential strategy to improve surgical outcomes by reducing complications, enhancing immune function, and promoting recovery.
Methods: A systematic search of PubMed, Scopus, and the Cochrane Library was conducted on 28 October 2024 in accordance with PRISMA guidelines. Systematic reviews and meta-analyses evaluating perioperative IMN versus standard care in adult patients undergoing GI cancer surgery were included in the search. The outcomes assessed included infectious and non-infectious complications, wound healing, hospital stay, and nutritional status. The study quality was evaluated using AMSTAR 2, and the meta-analysis was conducted using random-effects models to calculate the pooled effect sizes (risk ratios [RRs], odds ratios [ORs], mean differences [MDs]) with 95% confidence intervals (CIs).
Results: Sixteen systematic reviews and meta-analyses, including a total of 41,072 patients, were included. IMN significantly reduced infectious complications (RR: 0.62, 95% CI: 0.55-0.70; = 63.0%), including urinary tract infections (RR: 0.74, 95% CI: 0.61-0.89; = 0.0%) and wound infections (OR: 0.64, 95% CI: 0.55-0.73; = 34.4%). Anastomotic leak rates were notably lower (RR: 0.68, 95% CI: 0.62-0.75; = 8.2%). While no significant reduction in pneumonia risk was observed, non-infectious complications decreased significantly (RR: 0.83, 95% CI: 0.75-0.92; = 30.6%). IMN also reduced the length of hospital stay by an average of 1.92 days (MD: -1.92, 95% CI: -2.36 to -1.48; = 73.5%).
Conclusions: IMN provides significant benefits in GI cancer surgery, reducing complications and improving recovery. However, variability in protocols and populations highlight the need for standardization and further high-quality trials to optimize its application and to validate its efficacy in enhancing surgical care.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12300233 | PMC |
| http://dx.doi.org/10.3390/nu17142304 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Perioperative Immunonutrition in Gastrointestinal Oncology: A Comprehensive Umbrella Review and Meta-Analysis on Behalf of TROGSS-The Robotic Global Surgical Society.
Nutrients
July 2025
Department of Medicine, Academy of Applied Medical and Social Sciences-AMiSNS: Akademia Medycznych i Spolecznych Nauk Stosowanych, 52-300 Elbląg, Poland.
Introduction: Gastrointestinal (GI) cancers are associated with high morbidity and mortality. Surgical resection, the primary treatment, often induces immunosuppression and increases the risk of postoperative complications. Perioperative immunonutrition (IMN), comprising formulations enriched with omega-3 fatty acids, arginine, nucleotides, and antioxidants, has emerged as a potential strategy to improve surgical outcomes by reducing complications, enhancing immune function, and promoting recovery.
View Article and Find Full Text PDFEvaluating the role of pre-operative hemoglobin, albumin, lymphocyte, and platelet scores in predicting perioperative morbidity in rectal cancer patients.
Cir Cir
July 2025
Department of General Surgery, Bursa Yuksek Ihtisas Research and Training Hospital, Bursa. Turkey.
Objective: Our study aims to explore the predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score, calculated from routine blood tests measuring HALP levels, for perioperative morbidity in rectal cancer surgery patients.
Method: We conducted a retrospective study focusing on patients who underwent elective rectal cancer surgery from January 2017 to September 2023. The study analyzed demographic, clinical, and laboratory data, including the HALP score, to assess its correlation with perioperative morbidity using logistic and linear regression analyses.
Perioperative nutritional support in patients undergoing gastrointestinal surgery: Current views with an emphasis on prehabilitation efforts.
World J Gastrointest Surg
June 2025
Department of Inflammatory Bowel Disease Unit, "Metropolitan General" Hospital, Holargos 15562, Attica, Greece.
Continuously increasing reports in the international medical literature, along with current guidelines from international societies, support the view that perioperative enteral nutrition (EN) and immunonutrition offer significant benefits to patients with benign and/or malignant digestive disorders, including reduction of postoperative infections and hospital stay. A vital component of the rehabilitation of patients after major gastrointestinal surgery is a comprehensive nutritional rehabilitation program. It has been shown that implementing an integrated nutritional support program significantly improves patients' immune responses, accelerates wound healing processes, reduces pain and accompanying anxiety, and decreases hospital length of stay.
View Article and Find Full Text PDFBeneficial Outcomes of Immunoenhancing Nutritional Interventions in Perioperative Care for Oral Cancer: A Systematic Review and Meta-Analysis.
Cancers (Basel)
May 2025
The Guidelines Committee, Japanese Society of Oral and Maxillofacial Surgeons, Minato-ku, Tokyo 108-0014, Japan.
Background: This systematic review aimed to evaluate the efficacy of immunoenhancing nutritional therapy compared to conventional nutritional care in reducing perioperative complications in adult patients undergoing surgery for oral cancer. Given the unclear role of immunonutrition in this specific surgical setting, we synthesized available randomized controlled trials to assess outcomes such as surgical site infections, wound healing complications, hospital stay, and adverse events.
Methods: Patients who underwent planned oral cancer surgery were included.
Theimpact of obesity on perioperative care: Integrating ERAS protocols for improved surgical outcomes.
Maturitas
August 2025
First Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, "Alexandra" General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Obesity represents a global health crisis, affecting over 650 million adults worldwide and markedly influencing surgical outcomes, particularly in the context of gynecologic oncology. It serves as a considerable risk factor for perioperative complications, impacting metabolic, respiratory, immune, and cardiovascular functions. Patients with obesity undergoing surgical procedures in gynecologic oncology exhibit higher incidences of wound infections, thromboembolic events, respiratory failure, and extended hospital stays.
View Article and Find Full Text PDF